Business Context and Reporting Period
Company: Healthcare Trust of America, Inc. (Note: Metadata referenced "Healthcare Realty Trust Inc," but the filing text identifies the registrant as Healthcare Trust of America, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 13, 2010
Event: Entry into a Material Definitive Agreement and Creation of a Direct Financial Obligation.
Key Financial Metrics and Facility Terms
This filing details the establishment of a new unsecured revolving credit facility rather than reporting periodic operating results (revenue, profit, or cash flow).
- Facility Amount: $200,000,000 aggregate maximum principal amount.
- Capacity for Letters of Credit: Up to $20,000,000.
- Capacity for Swingline Loans: Up to $15,000,000.
- Term: Initial term of 12 months, extendable by two three-month periods subject to conditions.
- Interest Rates (ABR Loans): Prime/Federal Funds/LIBO base plus a margin of 1.60% to 2.50% based on leverage ratio.
- Interest Rates (Eurodollar Loans): Adjusted LIBO plus a margin of 2.60% to 3.50% based on leverage ratio.
- Unused Commitment Fee: 0.375% (if usage >50%) or 0.50% (if usage <50%).
- Extension Fees: 0.375% for the first extension; 0.50% for the second extension.
Material Changes and Liquidity
The primary material change is the addition of a $200 million unsecured credit facility to the company's capital structure. The filing does not provide comparative financial data (e.g., prior period debt levels or liquidity ratios) as this is a transactional report. The facility is designed to fund working capital, general corporate purposes, permitted acquisitions, and debt repayment. The actual credit availability is subject to loan-to-cost, loan-to-value, and debt service coverage ratios.
Outlook, Risks, and Covenants
Management Commentary: The company announced the facility via press release on October 15, 2010, indicating a strategic move to secure liquidity for growth and operations.
Covenants: The agreement includes standard affirmative and negative covenants, including limitations on:
- Incurrence of additional debt by the registrant and subsidiaries owning unencumbered assets.
- The nature of the Operating Partnership's business.
- Distributions by the Operating Partnership and subsidiaries owning unencumbered assets.
Expansion Option: The facility may be increased by up to an additional $200,000,000 subject to lender approval.
Investor Verification Checklist
- Verify the specific leverage ratios required to maintain the lower end of the interest rate margins (1.60% vs 2.50%).
- Review the attached Credit Agreement (Exhibit 10.1) for detailed definitions of "loan-to-cost" and "loan-to-value" ratios that determine actual borrowing capacity.
- Confirm the status of any existing debt that may be repaid using proceeds from this facility.
- Monitor compliance with distribution limitations imposed by the new covenants.